Zoledronic Acid
Links shared publicly online about this topic
Zoledronic acid (zoledronate, Zometa) - ONA
oncologynurseadvisor.com — “Zoledronic acid is a third-generation bisphosphonate prescribed to reduce pain from bony metastases, treat hypercalcemia of malignancy, and manage osteolytic lesions in multiple myeloma.” View full resource at oncologynurseadvisor.com
Most Recently Shared on September 1, 2010 at 2:45 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Zoledronic acid (zoledronate, Zometa) http://goo.gl/fb/nbiAs
ingentaconnect Zoledronic acid: Osteonecrosis of the jaw in an elderly patient: ...
ingentaconnect.com — “ingentaconnect Zoledronic acid: Osteonecrosis of the jaw in an elderly patient: ...” View full resource at ingentaconnect.com
Most Recently Shared on March 14, 2012 at 10:26 pm By:
Drugs and Devices OW OW Health
Zoledronic acid: Osteonecrosis of the jaw in an elderly patient: case report: (Source: Reactions) http://t.co/N0a9p18e
Zoledronic Acid & Prostate Cancer | LIVESTRONG.COM
livestrong.com — “Zoledronic Acid & Prostate Cancer. Aside from skin cancer, prostate cancer is the most common malignancy in American men, and it is the second leading cause of cancer death in this group, according to a January 2011...” View full resource at livestrong.com
Most Recently Shared on June 9, 2011 at 3:23 pm By:
Zoledronic Acid & Prostate Cancer: Aside from skin cancer, prostate cancer is the most common mali... http://bit.ly/imOqJr #womenshealth
Access : Bone: Zoledronic acid and teriparatide: better together? : Nature Reviews Endocrinology
nature.com — “Access : Bone: Zoledronic acid and teriparatide: better together? : Nature Reviews Endocrinology” View full resource at nature.com
Most Recently Shared on November 29, 2010 at 5:36 pm By:
NatureRevEndocrinol Endocrinology and Medical Journal
Zoledronic acid and teriparatide: better together? http://ow.ly/3gXQT #bone
Zoledronic acid may provide fracture protection in postmenopausal osteoporosis
endocrinetoday.com — “ASBMR Annual Meeting TORONTO — Data from two studies highlight an apparent role for zoledronic acid in effectively reducing fracture ris” View full resource at endocrinetoday.com
Most Recently Shared on October 22, 2010 at 3:44 pm By:
Zoledronic acid may provide fracture protection in postmenopausal osteoporosis http://bit.ly/ckKsQv
ingentaconnect Zoledronic acid: Flare-up of osteoarthritis: case report
ingentaconnect.com — “ingentaconnect Zoledronic acid: Flare-up of osteoarthritis: case report” View full resource at ingentaconnect.com
Most Recently Shared on October 19, 2010 at 4:13 am By:
Zoledronic acid: Flare-up of osteoarthritis: case report: (Source: Reactions)MedWorm Sponsor Message: Watch the ne... http://bit.ly/cXtw7q
Extending Zoledronic Acid Regimen Maintains Bone Density : Internal Medicine News
internalmedicinenews.com — “Extending Zoledronic Acid Regimen Maintains Bone Density : Internal Medicine News” View full resource at internalmedicinenews.com
Most Recently Shared on October 27, 2010 at 7:19 pm By:
Bob Finn - Medical News Net Health News
Extending #Zoledronic Acid Regimen Maintains #Bone Density. By @mitchelzoler for Internal Medicine News http://bit.ly/aZPat7 #osteoporosis
Zoledronic acid may have role other than fracture reduction
endocrinetoday.com — “Zoledronic acid reduced the risk for death by 25% in patients with hip fracture, but only 8% of the bisphosphonate’s death benefit was attribu” View full resource at endocrinetoday.com
Most Recently Shared on July 21, 2009 at 3:32 pm By:
Zoledronic acid may also have effect on CV events & pneumonia, in addition to bone. Read article, abstract here: http://tinyurl.com/mcholp
FDA approves Reclast (zoledronic acid) for osteoporosis in postmenopausal women
news-medical.net — “Reclast (zoledronic acid) Injection has been approved by the US Food and Drug Administration (FDA) as the first and only therapy to prevent postmenopausal osteoporosis for two years with a single dose. Reclast is already approved as a once-yearly infusion for the treatment of postmenopausal osteoporosis.” View full resource at news-medical.net
Most Recently Shared on June 1, 2009 at 2:02 pm By:
Osteoporosis News: FDA approves Reclast (zoledronic acid) for osteoporosis in postmenopausal w.. http://tinyurl.com/ktja8m
Denosumab Has Lower NNT Versus Zoledronic Acid for Prevention of SREs
onclive.com — “Fewer cancer patients need to be treated with denosumab to prevent one skeletal-related event due to bone metastases from solid tumors.” View full resource at onclive.com
Most Recently Shared on August 31, 2011 at 1:41 pm By:
Denosumab Has Lower Number Needed to Treat Versus Zoledronic Acid for Prevention of Skeletal-Related Events http://t.co/tj7TWjZ
Upfront zoledronic acid best for postmenopausal breast cancer patients
endocrinetoday.com — “Postmenopausal patients with breast cancer who receive adjuvant aromatase inhibitor therapy benefit from receiving upfront treatment with zoledr” View full resource at endocrinetoday.com
Most Recently Shared on October 14, 2011 at 7:54 pm By:
Upfront zoledronic acid best for #postmenopausal #breastcancer patients http://t.co/LCY2iG8w
Zoledronic acid demonstrates anti-angiogenic effects in metastatic lung cancer
news-medical.net — “A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of treatment, to prevent the cancer from spreading in the first place, Italian researchers have found.” View full resource at news-medical.net
Most Recently Shared on February 25, 2011 at 10:14 am By:
Lung Cancer News: Zoledronic acid demonstrates anti-angiogenic effects in metastatic lung cancer: A drug that is... http://bit.ly/eswTS0
Zoledronic Acid Shows Anticancer Activity In Multiple Myeloma Patients, As Well As Protecting Bone Health
medicalnewstoday.com — “Zoledronic acid improves survival in multiple myeloma patients versus the UK and European standard treatment of clodronic acid (sodium clodronate) in patients with multiple myeloma. Since overall” View full resource at medicalnewstoday.com
Most Recently Shared on December 5, 2010 at 1:05 pm By:
Zoledronic Acid Shows Anticancer Activity In Multiple Myeloma Patients, As Well As Protecting Bone Health http://mnt.to/3NwF #healthnews
FDA Alert: Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment
drugs.com — “FDA Alert: Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment” View full resource at drugs.com
Most Recently Shared on September 2, 2011 at 7:47 pm By:
FDA Alert - Reclast (zoledronic acid): New Contraindication and Updated Warning on Kidney Impairment - http://t.co/kydCwth
FDA Alert: Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment
drugs.com — “FDA Alert: Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment” View full resource at drugs.com
Most Recently Shared on September 1, 2011 at 9:04 pm By:
Drugs and Devices OW OW Health
Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney I... http://t.co/5XKQyOW #FDA
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Women's Health OW
Organizing womens health resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
